Department of Psychology, California State University, 5500 University Parkway, San Bernardino, CA, 92407, USA.
Psychopharmacology (Berl). 2014 Feb;231(4):651-62. doi: 10.1007/s00213-013-3280-9. Epub 2013 Sep 22.
Inactivating dopamine (DA) receptors in the caudate-putamen (CPu) attenuates basal and DA agonist-induced behaviors of adult rats while paradoxically increasing the locomotor activity of preweanling rats.
The purpose of this study was to determine (a) whether D1 or D2 receptor inactivation is responsible for the elevated locomotion shown by preweanling rats and (b) whether DA receptor inactivation produces a general state in which any locomotor-activating drug will cause a potentiated behavioral response.
Dimethyl sulfoxide (DMSO) or N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) was bilaterally infused into the CPu on postnatal day (PD) 17. In experiment 1, DA receptors were selectively protected from EEDQ-induced alkylation by pretreating rats with D1 and/or D2 antagonists. On PD 18, rats received bilateral microinjections of the DA agonist R(-)-propylnorapomorphine into the dorsal CPu, and locomotor activity was measured for 40 min. In subsequent experiments, the locomotion of DMSO- and EEDQ-pretreated rats was assessed after intraCPu infusions of the selective DA agonists SKF82958 and quinpirole, the partial agonist terguride, or after systemic administration of nonDAergic compounds.
Experiment 1 showed that EEDQ's ability to enhance the locomotor activity of preweanling rats was primarily due to the inactivation of D2 receptors. Consistent with this finding, only drugs that directly or indirectly stimulated D2 receptors produced a potentiated locomotor response in EEDQ-treated rats.
These results show that DA receptor inactivation causes dramatically different behavioral effects in preweanling and adult rats, thus providing additional evidence that the D2 receptor system is not functionally mature by the end of the preweanling period.
在尾壳核(CPu)中失活多巴胺(DA)受体可减弱成年大鼠的基础和 DA 激动剂诱导行为,而反常地增加幼鼠的运动活性。
本研究的目的是确定(a)D1 或 D2 受体失活是否导致幼鼠表现出升高的运动活性,以及(b)DA 受体失活是否产生一种普遍状态,使任何激活运动的药物都会引起增强的行为反应。
在出生后第 17 天(PD)将二甲基亚砜(DMSO)或 N-乙氧羰基-2-乙氧基-1,2-二氢喹啉(EEDQ)双侧注入 CPu。在实验 1 中,通过预先用 D1 和/或 D2 拮抗剂处理大鼠来选择性地保护 DA 受体免受 EEDQ 诱导的烷基化。在 PD 18 天,大鼠接受双侧 R(-)-丙基去甲阿莫福林(DA 激动剂)注入背侧 CPu,测量 40 分钟的运动活性。在随后的实验中,在 CPu 内输注选择性 DA 激动剂 SKF82958 和喹吡罗、部分激动剂曲古抑菌素或系统给予非 DA 化合物后,评估 DMSO 和 EEDQ 预处理大鼠的运动活性。
实验 1 表明,EEDQ 增强幼鼠运动活性的能力主要归因于 D2 受体的失活。与这一发现一致,只有直接或间接刺激 D2 受体的药物在 EEDQ 处理的大鼠中产生增强的运动反应。
这些结果表明,DA 受体失活在幼鼠和成年大鼠中引起明显不同的行为效应,从而提供了额外的证据,表明 D2 受体系统在幼年期结束前尚未完全成熟。